The chairman sees his fortune soar as the Fevicol-maker's stock appreciates on the back of strong volume-led sales growth and a push into high-growth businesses


Pidilite’s R&D lab in Mumbai’s Andheri
(This story appears in the 30 November, -0001 issue of Forbes India. To visit our Archives, click here.)